Cardiovascular risks of anemia correction with erythrocyte stimulating agents: Should blood viscosity be monitored for risk assessment?

Cardiovascular Drugs and Therapy

Volumn 24, Issue 2, 2010, Pages 151-160

  Jeong, Seul Ki ^a   Cho, Young I ^b   Duey, Marc ^c   Rosenson, Robert S ^d  

^a Chonbuk National University Medical School   (South Korea)

^b Drexel University   (United States)

^c ProMetrics Inc   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Blood donation; Blood pressure; Blood viscosity; Cardiovascular disease; Erythropoiesis stimulating agents; Erythropoietin; Hemoglobin; Hemorheology

Indexed keywords

ANTIANEMIC AGENT; ERYTHROCYTE STIMULATING AGENT; ERYTHROPOIETIN; HEMOGLOBIN; IRON; LONG ACTING DRUG; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; ANGINA PECTORIS; ARTERY THROMBOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD DONOR; BLOOD RHEOLOGY; BLOOD VISCOSITY; BRAIN MICROCIRCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIUM INJURY; ERYTHROCYTE DEFORMABILITY; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MENSTRUAL CYCLE; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONEAL DIALYSIS; PHLEBOTOMY; POLYCYTHEMIA; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VASCULAR ENDOTHELIUM; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS;

ANEMIA; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; HEMATINICS; HUMANS; RISK ASSESSMENT;

EID: 77955421489     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-010-6239-7     Document Type: Review

References (101)

1. TO Scholl ML Hediger 1994 Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome Am J Clin Nutr 59 492S 500S 8304287 discussion S-1S
2. G Weiss LT Goodnough 2005 Anemia of chronic disease N Engl J Med 352 1011 1023 10.1056/NEJMra041809 15758012 (Pubitemid 40349504)
3. P Stenvinkel 2001 The role of inflammation in the anaemia of end-stage renal disease Nephrol Dial Transplant 16 36 40 10.1093/ndt/16.10.1968 11590255
4. USRD System. USRD 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Diagestive and Kidney Diseases. Bethesda, MD, 2008.
5. Worldwide prevalence of anemia 1993-2005: WHO global database on anemia. In: de Benoist et al., editors. Geneva, Switzerland; 2008.
6. SE Kjeldsen B Dahlof RB Devereux, et al. 2000 Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Am J Hypertens 13 899 906 10.1016/S0895-7061(00)00280-6 10950398 (Pubitemid 30628225)
7. JS Silberberg DP Rahal DR Patton AD Sniderman 1989 Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease Am J Cardiol 64 222 224 10.1016/0002-9149(89)90462-1 2525871 (Pubitemid 19179369)
8. A Levin CR Thompson J Ethier, et al. 1999 Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 125 134 10.1016/S0272-6386(99)70118-6 10401026
9. N Bansal F Tighiouart D Weiner, et al. 2007 Anemia as a risk factor for kidney function decline in individuals with heart failure Am J Cardiol 99 1137 1142 10.1016/j.amjcard.2006.11.055 17437743 (Pubitemid 46560457)
10. A Palazzuoli M Gallotta F Iovine R Nuti DS Silverberg 2008 Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome Int J Clin Pract 62 281 286 18081797
11. RN Foley PS Parfrey JD Harnett GM Kent DC Murray PE Barre 1996 The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease Am J Kidney Dis 28 53 61 10.1016/S0272-6386(96)90130-4 8712222
12. JZ Ma J Ebben H Xia AJ Collins 1999 Hematocrit level and associated mortality in hemodialysis patients J Am Soc Nephrol 10 610 619 10073612 (Pubitemid 29117643)
13. MA Pfeffer EA Burdmann CY Chen, et al. 2009 Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Am J Kidney Dis 54 59 69 10.1053/j.ajkd.2009.04.008 19501439
14. TB Drueke F Locatelli N Clyne, et al. 2006 Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2071 2084 10.1056/NEJMoa062276 17108342 (Pubitemid 44749316)
15. AK Singh L Szczech KL Tang, et al. 2006 Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2085 2098 10.1056/NEJMoa065485 17108343 (Pubitemid 44749317)
16. A Besarab WK Bolton JK Browne, et al. 1998 The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 584 590 10.1056/ NEJM199808273390903 9718377 (Pubitemid 28385655)
17. PS Parfrey M Lauve D Latremouille-Viau P Lefebvre 2009 Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis Clin J Am Soc Nephrol 4 755 762 10.2215/CJN.02730608 19339417
18. Pfeffer MA, Burdmann EA, Chen C-Y, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009:NEJMoa0907845.
19. EF Unger AM Thompson MJ Blank R Temple 2010 Erythropoiesis-stimulating agents-time for a reevaluation N Engl J Med 362 189 192 10.1056/NEJMp0912328 20054037
20. J Danesh R Collins R Peto GD Lowe 2000 Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease Eur Heart J 21 515 520 10.1053/euhj.1999.1699 10775006 (Pubitemid 30148316)
21. G Ciuffetti G Schillaci R Lombardini M Pirro G Vaudo E Mannarino 2005 Prognostic impact of low-shear whole blood viscosity in hypertensive men Eur J Clin Investig 35 93 98 10.1111/j.1365-2362.2005.01437.x (Pubitemid 40222810)
22. BI Levy EL Schiffrin J-J Mourad, et al. 2008 Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus Circulation 118 968 976 10.1161/CIRCULATIONAHA.107.763730 18725503
23. HC Kwaan A Bongu 1999 The hyperviscosity syndromes Semin Thromb Hemost 25 199 208 10.1055/s-2007-994921 10357087
24. TW Jax AJ Peters G Plehn FC Schoebel 2009 Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes-a two year follow-up of 243 patients Cardiovasc Diabetol 8 48 10.1186/1475-2840-8-48 19735543
25. YI Cho MP Mooney DJ Cho 2008 Hemorheological disorders in diabetes mellitus J Diabetes Sci Technol 2 1130 1138 19885302
26. E Cecchi R Marcucci D Poli, et al. 2006 Hyperviscosity as a possible risk factor for cerebral ischemic complications in atrial fibrillation patients Am J Cardiol 97 1745 1748 10.1016/j.amjcard.2006.01.034 16765126 (Pubitemid 43817861)
27. RB Devereux DB Case MH Alderman TG Pickering S Chien JH Laragh 2000 Possible role of increased blood viscosity in the hemodynamics of systemic hypertension Am J Cardiol 85 1265 1268 10.1016/S0002-9149(00)00744-X 10802017 (Pubitemid 30232830)
28. MV Kameneva MJ Watach HS Borovetz 1999 Gender difference in rheologic properties of blood and risk of cardiovascular diseases Clin Hemorheol Microcirc 21 357 363 10711771
29. GD Sloop DW Garber 1997 The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans Clin Sci 92 473 479 9176020
30. RS Rosenson A McCormick EF Uretz 1996 Distribution of blood viscosity values and biochemical correlates in healthy adults Clin Chem 42 1189 1195 8697575
31. FG Fowkes GD Lowe A Rumley SE Lennie FB Smith PT Donnan 1993 The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years Eur Heart J 14 597 601 8508852
32. WC Smith GD Lowe AJ Lee H Tunstall-Pedoe 1992 Rheological determinants of blood pressure in a Scottish adult population J Hypertens 10 467 472 10.1097/00004872-199205000-00010 1317908
33. G de Simone RB Devereux S Chien MH Alderman SA Atlas JH Laragh 1990 Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults Circulation 81 107 117 2297818
34. E Ernst W Koenig A Matrai B Filipiak J Stieber 1988 Blood rheology in healthy cigarette smokers. Results from the MONICA project, Augsburg Arteriosclerosis 8 385 388 3395274
35. J Levenson AC Simon FA Cambien C Beretti 1987 Cigarette smoking and hypertension. Factors independently associated with blood hyperviscosity and arterial rigidity Arteriosclerosis 7 572 577 3689203
36. E Ernst T Weihmayr M Schmid M Baumann A Matrai 1986 Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity Atherosclerosis 59 263 269 10.1016/0021-9150(86)90121-8 3964347 (Pubitemid 16163841)
37. RL Letcher S Chien TG Pickering JE Sealey JH Laragh 1981 Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration Am J Med 70 1195 1202 10.1016/0002-9343(81)90827-5 7234890 (Pubitemid 11072112)
38. LJ Tamariz JH Young JS Pankow, et al. 2008 Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) Study Am J Epidemiol 168 1153 1160 10.1093/aje/kwn243 18931370
39. SG Frangos V Gahtan B Sumpio 1999 Localization of atherosclerosis: role of hemodynamics Arch Surg 134 1142 1149 10.1001/archsurg.134.10.1142 10522862 (Pubitemid 29473207)
40. AM Malek SL Alper S Izumo 1999 Hemodynamic shear stress and its role in atherosclerosis JAMA 282 2035 2042 10.1001/jama.282.21.2035 10591386
41. AJ Lee PI Mowbray GD Lowe A Rumley FG Fowkes PL Allan 1998 Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study Circulation 97 1467 1473 9576427
42. YI Cho KR Kensey 1991 Effects of the non-Newtonian viscosity of blood on flows in a diseased arterial vessel. Part 1: Steady flows Biorheology 28 241 262 1932716
43. S Fukuda T Yasu N Kobayashi N Ikeda GW Schmid-Schonbein 2004 Contribution of fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hypertensive rat Circ Res 95 100 108 10.1161/01.RES.0000133677. 77465.38 15166092 (Pubitemid 38931841)
44. JF Brun C Bouchahda D Chaze AA Benhaddad JP Micallef J Mercier 2000 The paradox of hematocrit in exercise physiology: which is the "normal" range from an hemorheologist's viewpoint? Clin Hemorheol Microcirc 22 287 303 11081466
45. Fung YC. Biomechanics: mechanical properties of living tissues. New York: Springer-Verlag; 1981. p. 108-13.
46. Gaehtgens P, Pries AR, Ley K. Structural hemodynamic and rheological characteristics of blood flow in the circulation. In: Chien S, Dormandy J, Ernst E, Matrai A, editors. Clinical hemorheology: applications in cardiovascular and haematological disease, diabetes, surgery, and gynecology. Boston: Martinus Niihoff; 1987. p. 97-124.
47. H Leonhardt HR Arntz UH Klemens 1977 Studies of plasma viscosity in primary hyperlipoproteinaemia Atherosclerosis 28 29 40 10.1016/0021-9150(77) 90196-4 199202 (Pubitemid 8171631)
48. AH Seplowitz S Chien FR Smith 1981 Effects of lipoproteins on plasma viscosity Atherosclerosis 38 89 95 10.1016/0021-9150(81)90107-6 7470209 (Pubitemid 11138610)
49. RS Rosenson AL Baker MJ Chow RV Hay 1990 Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis Gastroenterology 98 1351 1357 2323525
50. JA Dormandy 1974 Medical and engineering problems of blood viscosity Biomed Eng 9 284 289 4276960
51. GD Lowe 1986 Blood rheology in arterial disease Clin Sci (Lond) 71 137 146
52. RS Rosenson S Shott CC Tangney 2002 Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity Atherosclerosis 161 433 439 10.1016/S0021-9150(01)00656-6 11888528 (Pubitemid 34219198)
53. TD Stamos RS Rosenson 1999 Low high density lipoprotein levels are associated with an elevated blood viscosity Atherosclerosis 146 161 165 10.1016/S0021-9150(99)00114-8 10487499 (Pubitemid 29371874)
54. A Hoieggen E Fossum A Moan E Enger SE Kjeldsen 1998 Whole-blood viscosity and the insulin-resistance syndrome J Hypertens 16 203 210 10.1097/00004872- 199816020-00011 9535148 (Pubitemid 28085293)
55. GD Lowe 1992 Blood viscosity, lipoproteins, and cardiovascular risk Circulation 85 2329 2331 1591850
56. C Otto WO Richter P Schwandt 2000 Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen Metabolism 49 810 813 10.1053/meta.2000.6264 10877212
57. GD Lowe FG Fowkes J Dawes PT Donnan SE Lennie E Housley 1993 Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study Circulation 87 1915 1920 8504504
58. W Koenig M Sund B Filipiak A Doring H Lowel E Ernst 1998 Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992 Arterioscler Thromb Vasc Biol 18 768 772 9598836
59. GD Lowe AJ Lee A Rumley JF Price FG Fowkes 1997 Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study Br J Haematol 96 168 173 10.1046/j.1365-2141.1997.8532481.x 9012704 (Pubitemid 27047547)
60. KS Cunningham AI Gotlieb 2005 The role of shear stress in the pathogenesis of atherosclerosis Lab Invest 85 9 23 10.1038/labinvest.3700299 15568038 (Pubitemid 41021302)
61. KR Kensey 2003 Rheology: an overlooked component of vascular disease Clin Appl Thromb Hemost 9 93 99 10.1177/107602960300900201 12812376
62. MH Friedman CB Bargeron OJ Deters GM Hutchins FF Mark 1987 Correlation between wall shear and intimal thickness at a coronary artery branch Atherosclerosis 68 27 33 10.1016/0021-9150(87)90090-6 3689481 (Pubitemid 17151102)
63. CG Caro JM Fitz-Gerald RC Schroter 1969 Arterial wall shear and distribution of early atheroma in man Nature 223 1159 1160 10.1038/2231159a0 5810692
64. P Libby PM Ridker A Maseri 2002 Inflammation and atherosclerosis Circulation 105 1135 1143 10.1161/hc0902.104353 11877368 (Pubitemid 34212626)
65. TP Tuomainen R Salonen K Nyyssonen JT Salonen 1997 Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland BMJ 314 793 794 9080998
66. H Hemila M Paunio 1997 Blood donation, body iron stores, and risk of myocardial infarction. Confidence intervals and possible selection bias call study results into question BMJ 314 1830 1831 9224100
67. JT Salonen TP Tuomainen R Salonen TA Lakka K Nyyssonen 1998 Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study Am J Epidemiol 148 445 451 9737556
68. GD Sloop 1998 Possible association of a reduction in cardiovascular events with blood donation Heart 79 422 9616358
69. X Cliville C Bofill J Joven, et al. 1998 Hemorheological, coagulative and fibrinolytic changes during autologous blood donation Clin Hemorheol Microcirc 18 265 272 9741667
70. K Janetzko H Kluter H Kirchner KF Klotz 2001 The effect of moderate hypovolaemia on microcirculation in healthy older blood donors Anaesthesia 56 103 107 10.1046/j.1365-2044.2001.01787.x 11167468 (Pubitemid 32185878)
71. T Gordon WB Kannel MC Hjortland PM McNamara 1978 Menopause and coronary heart disease. The Framingham Study Ann Intern Med 89 157 161 677576
72. DG Meyers D Strickland PA Maloley JK Seburg JE Wilson BF McManus 1997 Possible association of a reduction in cardiovascular events with blood donation Heart 78 188 193 9326996
73. LR Zacharski BK Chow PS Howes, et al. 2007 Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial JAMA 297 603 610 10.1001/jama.297.6.603 17299195
74. JL Sullivan 1981 Iron and the sex difference in heart disease risk Lancet 1 1293 1294 10.1016/S0140-6736(81)92463-6 6112609
75. PR Humphrey J Michael TC Pearson 1980 Management of relative polycythaemia: studies of cerebral blood flow and viscosity Br J Haematol 46 427 433 10.1111/j.1365-2141.1980.tb05989.x 6160869
76. PR Humphrey GH Du Boulay J Marshall, et al. 1979 Cerebral blood-flow and viscosity in relative polycythaemia Lancet 2 873 877 10.1016/S0140-6736(79) 92687-4 90967
77. HS Gilbert 2003 Modern treatment strategies in polycythemia vera Semin Hematol 40 26 29 12682879
78. G Vautier M Murray JK Olynyk 2001 Hereditary haemochromatosis: detection and management Med J Aust 175 418 421 11700835
79. A Tefferi 2003 A contemporary approach to the diagnosis and management of polycythemia vera Curr Hematol Rep 2 237 241 12901345
80. RJ Laudicina VA Legrys 2001 Hereditary hemochromatosis: a case study and review Clin Lab Sci 14 196 208 11517631 quiz 20-2
81. JW Eschbach MH Abdulhadi JK Browne, et al. 1989 Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial Ann Intern Med 111 992 1000 2688507
82. A Besarab DA Goodkin AR Nissenson 2008 The normal hematocrit study-follow-up N Engl J Med 358 433 434 10.1056/NEJMc076523 18216370 (Pubitemid 351159266)
83. H Ehrenreich K Weissenborn H Prange, et al. 2009 Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 e647 e656 10.1161/STROKEAHA.109.564872 19834012
84. T Frietsch MH Maurer J Vogel M Gassmann W Kuschinsky KF Waschke 2007 Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpressing transgenic mice with excessive erythrocytosis J Cereb Blood Flow Metab 27 469 476 10.1038/sj.jcbfm.9600360 16804549
85. L Szapary B Horvath Z Marton, et al. 2004 Hemorheological disturbances in patients with chronic cerebrovascular diseases Clin Hemorheol Microcirc 31 1 9 15272148
86. I Velcheva N Antonova E Titianova P Damianov N Dimitrov V Dimitrova 2008 Hemorheological disturbances in cerebrovascular diseases Clin Hemorheol Microcirc 39 391 396 18503150
87. BM Coull N Beamer P de Garmo, et al. 1991 Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke Stroke 22 162 168 2003279
88. BI Shand AL Buttimore KL Lynn RR Bailey RA Robson 1994 Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity Ren Fail 16 407 413 10.3109/08860229409044880 8059023
89. MH Lim YI Cho SK Jeong 2009 Homocysteine and pulsatility index of cerebral arteries Stroke 40 3216 3220 10.1161/STROKEAHA.109.558403 19628800
90. A Phrommintikul SJ Haas M Elsik H Krum 2007 Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis Lancet 369 381 388 10.1016/S0140-6736(07)60194-9 17276778 (Pubitemid 46188479)
91. S Vaisman K Kensey YI Cho 2009 Effect of hemodialysis on whole blood viscosity Int J Artif Organs 32 329 335 19670184
92. S Kim YI Cho WN Hogenauer KR Kensey 2002 A method of isolating surface tension and yield stress effects in a U-shaped scanning capillary-tube viscometer using a Casson model J Non-Newtonian Fluid Mech 103 205 219 10.1016/S0377-0257(02)00004-6 (Pubitemid 34500114)
93. S Wang AH Boss KR Kensey RS Rosenson 2003 Variations of whole blood viscosity using Rheolog-a new scanning capillary viscometer Clin Chim Acta 332 79 82 10.1016/S0009-8981(03)00125-6 12763283 (Pubitemid 36577492)
94. S Carroll CB Cooke RJ Butterly 2000 Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness Blood Coagul Fibrinolysis 11 71 78 10691101
95. E Ernst 1995 Haemorheological consequences of chronic cigarette smoking J Cardiovasc Risk 2 435 439 10.1097/00043798-199510000-00008 8749271
96. GD Lowe MM Drummond CD Forbes JC Barbenel 1980 The effects of age and cigarette-smoking on blood and plasma viscosity in men Scott Med J 25 13 17 7209492
97. FG Fowkes JP Pell PT Donnan, et al. 1994 Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity Arterioscler Thromb 14 862 868 8199175
98. L Coppola F Caserta D De Lucia, et al. 2000 Blood viscosity and aging Arch Gerontol Geriatr 31 35 42 10.1016/S0167-4943(00)00063-7 10989162
99. M Feriani PL Kimmel J Kurantsin-Mills JP Bosch 1992 Effect of renal replacement therapy on viscosity in end-stage renal disease patients Am J Kidney Dis 19 131 139 1739094
100. D McGregor B Shand K Lynn 2000 A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease Nephron 85 215 220 10.1159/000045664 10867536
101. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl. 2006;103:S3-11, Nov.